What is the differential diagnosis for a 46-year-old woman presenting with oral lichen planus and multiple strokes of unknown etiology?

Differential Diagnosis for 46-Year-Old Woman with Oral Lichen Planus and Multiple Cryptogenic Strokes

This presentation demands immediate investigation for systemic vasculitis, antiphospholipid syndrome, and other autoimmune/inflammatory conditions that can cause both oral mucosal disease and cerebrovascular events.

Primary Differential Considerations

1. Systemic Lupus Erythematosus (SLE)

• Can present with oral lichenoid lesions that mimic lichen planus clinically and histologically
• Well-established cause of stroke in young patients through multiple mechanisms (vasculitis, antiphospholipid antibodies, cardiac emboli from Libman-Sacks endocarditis)
• The combination of oral mucosal disease and recurrent strokes in a middle-aged woman is highly suggestive
• Workup needed: ANA, anti-dsDNA, anti-Smith, complement levels (C3, C4), complete blood count, urinalysis

2. Antiphospholipid Syndrome (APS)

• Primary cause of cryptogenic stroke in young adults, particularly women
• Can occur as isolated syndrome or secondary to SLE
• May present with oral mucosal manifestations
• Workup needed: Anticardiolipin antibodies (IgG and IgM), anti-β2 glycoprotein I antibodies, lupus anticoagulant (requires confirmation at 12 weeks)

3. Behçet's Disease

• Causes recurrent oral ulceration (though typically aphthous rather than classic lichen planus pattern)
• Well-documented cause of stroke through CNS vasculitis and venous thrombosis
• More common in patients of Mediterranean, Middle Eastern, or Asian descent
• Look for: Genital ulcers, pathergy test positivity, ocular involvement, skin lesions

4. Hepatitis C Virus (HCV) Infection

• Strong association with oral lichen planus 1
• Associated with cryoglobulinemia, which can cause vasculitis and stroke
• The relationship with HCV is particularly strong in certain geographical areas 1
• Workup needed: HCV antibody, HCV RNA if positive, cryoglobulins

5. Primary CNS Vasculitis

• Can cause multiple strokes of unclear etiology
• May have systemic manifestations including oral mucosal involvement
• Diagnosis of exclusion requiring extensive workup
• Workup needed: ESR, CRP, vessel imaging (MRA or CTA), consider cerebral angiography if high suspicion

6. Cerebral Venous Sinus Thrombosis (CVST)

• Can present with stroke-like symptoms
• Associated with hypercoagulable states and autoimmune conditions
• Imaging needed: MRV or CTV to evaluate venous sinuses 2

Essential Diagnostic Workup

Immediate Laboratory Investigations

Based on the clinical presentation, the following tests are mandatory 3:

Autoimmune panel:

• ANA, anti-dsDNA, anti-Smith antibodies
• Anti-smooth muscle antibodies (present in 8.4% of OLP patients) 3
• Antiphospholipid antibodies (anticardiolipin IgG/IgM, anti-β2 glycoprotein I, lupus anticoagulant)
• Complement levels (C3, C4)
• ANCA panel (if vasculitis suspected)

Hematologic studies:

• Complete blood count with differential
• Hemoglobin, iron studies, vitamin B12, folate (deficiencies found in 21.9%, 13.6%, 7.1%, and 0.3% of OLP patients respectively) 3
• Serum homocysteine (elevated in 14.8% of OLP patients) 3
• Coagulation studies including protein C, protein S, antithrombin III

Infectious workup:

• HCV antibody and RNA 1
• HIV testing
• RPR/VDRL (syphilis can cause both oral lesions and stroke)

Other:

• ESR, CRP
• Thyroid function tests and thyroid autoantibodies (thyroglobulin and thyroid microsomal antibodies present in 21.3% and 24.4% of OLP patients) 3
• Fasting glucose and HbA1c

Imaging Studies for Stroke Workup

Per current guidelines for cryptogenic stroke evaluation 4:

Standard imaging:

• Brain MRI with and without contrast (to evaluate stroke pattern, exclude vasculitis, tumor)
• MRA head and neck or CTA (to evaluate for vasculopathy)
• MRV (to exclude venous sinus thrombosis) 2

Cardiac evaluation:

• Transthoracic echocardiography (minimum)
• Consider transesophageal echocardiography if high suspicion for cardiac source
• Extended cardiac monitoring (>24 hours, ideally 30 days) to detect paroxysmal atrial fibrillation 4

Oral Lesion Confirmation

Biopsy is essential to confirm oral lichen planus diagnosis and exclude:

• Oral lichenoid drug reaction
• Dysplasia or squamous cell carcinoma (1.43% transformation rate, 5.13% if dysplasia present) 5
• Lupus erythematosus
• Mucous membrane pemphigoid
• Chronic graft-versus-host disease 6

The biopsy should demonstrate band-like lymphocytic infiltrate at the epithelial-connective tissue interface with liquefaction degeneration of the basal cell layer 5.

Critical Clinical Pitfalls

1. Do not assume the oral lesions and strokes are unrelated - this combination strongly suggests systemic autoimmune disease
2. Do not delay antiphospholipid antibody testing - this is a treatable cause of recurrent stroke
3. Do not accept "cryptogenic stroke" without exhaustive workup in a 46-year-old woman with concurrent inflammatory oral disease
4. Do not overlook HCV testing - the association with both OLP and stroke (through cryoglobulinemia) is well-established 1
5. Recognize that serum autoantibodies are present in 60.9% of OLP patients 3, making autoimmune screening mandatory

Management Implications

If systemic autoimmune disease is confirmed:

• Anticoagulation decisions must be made in consultation with neurology and rheumatology
• Immunosuppressive therapy may be required for both stroke prevention and OLP management
• Topical corticosteroids remain first-line for OLP symptoms 7, but systemic disease requires systemic treatment

If no systemic cause identified after complete workup:

• Consider ESUS (Embolic Stroke of Undetermined Source) classification
• Long-term antiplatelet therapy
• Aggressive cardiovascular risk factor modification
• Separate management of OLP with topical superpotent corticosteroids 7
• Lifelong surveillance for malignant transformation of OLP 5